Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study
Public ClinicalTrials.gov record NCT02520245. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study has been designed to collect long-term follow-up information for patients who received REGN2810 in other clinical studies and to allow re-treatment for eligible patients.
Study identification
- NCT ID
- NCT02520245
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2015 (Type not available)
- Primary completion
- Nov 2023 (Estimated)
- Completion
- Nov 2023 (Estimated)
- Last update posted
- Nov 7, 2016
2015 – 2023
United States locations
- U.S. sites
- 9
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope National Medical Center | Duarte | California | — | — |
| Sarah Cannon Research Institute at HealthONE | Denver | Colorado | — | — |
| Washington University School of Medicine Siteman Cancer Center | St Louis | Missouri | — | — |
| Laura & Isaac Perlmutter Cancer Center | New York | New York | — | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | — | — |
| Stephenson Cancer Center | Oklahoma City | Oklahoma | — | — |
| Providence Portland Medical Center | Portland | Oregon | — | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | — | — |
| START South Texas Accelerated Research Therapeutics | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02520245, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2016 · Synced Nov 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02520245 live on ClinicalTrials.gov.